Jeff Galvin speaks With Students at Georgetown University
Jeff Galvin CEO of American Gene Technologies (AGT) speaks with students of the Academy Health program at Georgetown University and shares career advice, his career path & developing a cure for HIV with gene therapy.
Advances in gene technologies and the resulting cures are accelerating exponentially while costs are coming down. If you were in Silicon Valley for the last 35 years, you’d recognize parallels to many previous high-tech “explosions” such as microcomputers, software and the Internet. “Moore’s Law” now applies to drug development and the next big startup could be up in a garage near you! Forget zeroes and ones… A-C-G-T is the new growth area of programming and real-world solutions. Viva la revolution!
Takeaways
- Cells are organic computers. Reprogramming them is incredibly powerful in treating and curing disease.
- Gene technologies are advancing at lightning speed. Our ability to change DNA with gene and cell therapeutic approaches in a targeted, safe, effective manner is making solutions to 1000’s of formerly untreatable diseases practical in the near term, many in the next 5-10 years.
- Get ready for market disruption with insights into Pharma, care-delivery, insurance and government impacts and opportunities.
